Sproxil

Sproxil

Mobile Product Authentication (MPA)

Other | Ghana | Access to Information |

 

Overview

Sproxil is combating the global counterfeit drug market through a Mobile Product Authentication (MPA) solution that enables consumers to verify the authenticity of pharmaceutical products. Sproxil s MPA solution allows customers to send a free text message containing a code found on a drug to Sproxil s servers which immediately respond and indicate whether the drug is genuine or fake. Sproxil has set up Africa s first national mobile based anti counterfeit service in Nigeria and Acumen Fund s investment will enable the company to expand into Kenya and India.

Industry

Legal Structure

Operating Status

Employees

Other Other Legal Structure Operating 11 - 50 employees

Funding and Financing Rounds


Team


Impact

Social Objectives:

Environmental Objectives:

Operational Impact:


Impact Reports & Metrics


Offices

US Headquarter


Boston, Massachusetts US



Explore

Revision History


Quick Search



  • Global  
  • Africa  
  • Americas  
  • Asia  
  • Europe  
  • Oceania  


Incoming

Twitter

Tweet from Sproxil, Inc: Sproxil is hiring a Marketing Communications Specialist from Nigeria. Interested candidates can apply here: https://t.co/L5vHp5GEVG Posted Tue Nov 7 2:46 am

Tweet from BellaNaija.com: RT @bellanaija: Did you know you could verify every product you purchase with @sproxil? #BNsc https://t.co/bCPGznjiM2 Posted Tue Nov 7 2:09 am

Tweet from BellaNaija.com: RT @bellanaija: Be mindful of what you take in. Say No to counterfeit drugs. Cc @sproxil #BNSc https://t.co/bCPGznjiM2 Posted Tue Nov 7 1:58 am

Tweet from Sproxil, Inc: The scourge of fake/counterfeit medicine is especially harsh in Africa, which is why our launch today in Tanzania is of great significance. Posted Thu Oct 26 7:28 am

Tweet from Sproxil, Inc: Thanks to the support of @HDIFtz Sproxil launches Mobile Product Authentication in Tanzania today. Press release coming up shortly. Posted Thu Oct 26 7:15 am

Tags

COPYRIGHT 2017 IMPACTSPACE. ALL RIGHTS RESERVED.